TBG Diagnostics Limited (ASX: TDL)

Company Profile: TBG Diagnostics Limited (ASX: TDL) develops, manufactures and markets nucleic acid test kits and offers related services. The Company serves the molecular diagnostic industry around the world. The company is headed by Mr. Jitto Arulampalam, who is also an Executive Chairman of the company. The company’s Registered and Principal Office is situated in Melbourne, Australia. The company came into existence in the Year 1999.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report